Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412893
Status:
COMPLETED
Last Update Posted:
2019-04-05
First Post:
2006-12-18
Brief Title:
Isavuconazole BAL8557 for Primary Treatment of Invasive Aspergillosis
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Organization Data
Organization:
Astellas Pharma Inc
Class:
INDUSTRY
Study ID:
9766-CL-0104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Astellas Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Basilea Pharmaceutica International Ltd | INDUSTRY |